文献速递系统性红斑狼疮其他结缔组织病

疫苗相关狼疮及器官受累:VAERS数据库1990-2025年药物警戒分析

Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990-2025.
PubMed 文献 · Semin Arthritis Rheum · 2026-01-23

基于VAERS数据库1990-2025年1130余万例不良事件报告,识别1976例(0.017%)疫苗相关狼疮,从接种到症状中位时间8天,最常见表现为肌肉骨骼与结缔组织病(82.94%),40.48%为严重结局、3.13%死亡。HPV和HBV疫苗与狼疮不良事件及特定器官受累相关,COVID-19、流感和带状疱疹疫苗未见关联。

要点

  • 疫苗相关狼疮总体少见(0.017%),表现以肌肉骨骼和皮肤为主,肾和神经系统受累罕见。
  • HPV疫苗与狼疮不良事件相关,尤其肌肉骨骼/结缔组织、肾脏和神经系统受累。
  • HBV疫苗与狼疮不良事件相关,主要为肌肉骨骼/结缔组织受累;COVID-19、流感和带状疱疹疫苗未见关联。

核心结论

  • 疫苗相关狼疮不常见且表现总体较轻,HPV和HBV疫苗与狼疮不良事件存在较强关联并涉及不同器官受累。

研究设计与样本

  • 基于VAERS数据库1990-2025年数据的药物警戒分析,采用不成比例分析和病例对照分析评估疫苗与SLE及器官受累的关系。

主要发现

  • 在11,301,263例不良事件中识别1976例(0.017%)疫苗相关狼疮,从接种到症状中位时间8(0-8,070)天。
  • 最常见表现为肌肉骨骼和结缔组织病(82.94%),其次为皮肤和皮下组织病变(10.83%),肾脏和神经系统受累罕见。
  • 702例(40.48%)患者为严重结局,22例(3.13%)死亡。
  • HPV疫苗与狼疮不良事件相关,尤其肌肉骨骼/结缔组织、肾脏和神经系统受累;HBV疫苗亦相关,尤其肌肉骨骼/结缔组织受累。
  • COVID-19、流感和带状疱疹疫苗与狼疮不良事件及特定器官受累无关联;重组蛋白疫苗与狼疮不良事件显示显著关联。

关键数值与推荐

  • 疫苗相关狼疮占VAERS不良事件0.017%(1976/11,301,263)。
  • 严重结局占40.48%(702例),死亡占3.13%(22例)。
  • 肌肉骨骼和结缔组织病占82.94%,皮肤和皮下组织病变占10.83%。

临床怎么用

  • 对接种HPV或HBV疫苗后出现肌肉骨骼/结缔组织症状者,应警惕疫苗相关狼疮可能并进行评估。
  • 疫苗相关狼疮总体表现较轻,肾脏和神经系统受累罕见,但严重结局占40.48%,需关注重症识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The relationships between vaccines and the development of systemic lupus erythematosus (SLE) and related organ involvements remain unclear. METHODS: We analyzed data from the Vaccine Adverse Event Reporting System (VAERS) during the period of 1990 to 2025 to determine the incidence of vaccine-associated SLE over time. The relationships between vaccines and the development of SLE and organ involvements were assessed by disproportionality and case-control analyses. RESULTS: 1976 (0.017%) cases of vaccine-associated lupus were identified amongst 11,301,263 adverse events (AEs) reported in VAERS (1990-2025). Median time from vaccination to symptom onset was 8 (0-8,070) days. The most common manifestations are musculoskeletal and connective tissue disorders (82.94%) followed by skin and subcutaneous tissue lesions (10.83%), while kidney and nervous system involvements are rare. 702 (40.48%) patients had serious outcomes, and 22 (3.13%) died. Human papilloma virus (HPV) vaccine is associated with lupus AEs, especially musculoskeletal/connective tissue disorders, kidney and nervous system involvements. Hepatitis B virus (HBV) vaccine also shows correlations with lupus AEs, particularly musculoskeletal/connective tissue disorders. COVID-19, influenza and zoster vaccines show no relationship with lupus AEs and specific organ involvements. Recombinant protein vaccines show significant links with lupus AEs. CONCLUSION: Vaccine-associated lupus is uncommon and manifestations are generally mild. HPV and HBV vaccines show strong associations with lupus AEs with distinct organ involvements.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Xie R, Cheong LY, Zhang D, et al. Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990-2025. Semin Arthritis Rheum. 2026. PMID: 41616382. doi:10.1016/j.semarthrit.2026.152933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。